United States 116th Congress Status: Died 1 D cosponsors

HR 8167 — Coronavirus Testing Capacity Expansion Act

Last action — Referred to the House Committee on Energy and Commerce.

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. Died in session

This bill died with 116th Congress. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.

Summary

Requires the Department of Health and Human Services to directly reimburse laboratories for certain tests and related services during the COVID-19 (i.e., coronavirus disease 2019) emergency and expands the categories of laboratories eligible for certain COVID-19 relief funding. Specifically, veterinary and biotechnology company laboratories may receive federal COVID-19 funds for activities related to testing. Currently, this funding is limited to academic, commercial, public health, or hospital laboratories.

Bill Text

We don't have the full text on file for this bill yet.

Read HR 8167 on the official United States source →

Action History

  1. Referred to the House Committee on Energy and Commerce.

  2. Introduced in House

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 0 co-sponsors · 546 not signed on

Sponsors (1)

Co-sponsors (0)

None.

Not signed on (546)

546 members have not signed on to this bill.

Show all 546 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

Health Appropriations Cardiovascular and respiratory health Department of Health and Human Services Emergency medical services and trauma care Employee hiring Executive agency funding and structure Genetics Health personnel Health programs administration and funding Health technology, devices, supplies Infectious and parasitic diseases Medical tests and diagnostic methods Veterinary medicine and animal diseases
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does HR 8167 do?
Requires the Department of Health and Human Services to directly reimburse laboratories for certain tests and related services during the COVID-19 (i.e., coronavirus disease 2019) emergency and expands the categories of laboratories eligible for certain COVID-19 relief funding. Specifically, veterinary and biotechnology company laboratories may receive federal COVID-19 funds for activities related to testing. Currently, this funding is limited to academic, commercial, public health, or hospital laboratories.
Who sponsors HR 8167?
HR 8167 is sponsored by Charlie Crist (D).
What is the current status of HR 8167?
This bill died with 116th Congress. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
Where can I track HR 8167?
Track HR 8167 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HR 8167

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HR 8167

Last checked for changes about 8 hours ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →